Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heat-stable carbetocin and tranexamic acid for postpartum hemorrhage prevention and treatment in basic emergency obstetric care facilities
PACTR202302476608339Recruiting
- Sponsor
- United Nations Population Fund
- Start
- Jan 2022
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
Open-label trial of carbetocin and tranexamic acid in postpartum hemorrhage (PPH) (4 arms), sponsored by United Nations Population Fund. Started Jan 2022; status: recruiting.
02
Drugs
carbetocintranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202302476608339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202302476608339.